Infant Growth and Microbiome Study 2

婴儿生长和微生物组研究 2

基本信息

  • 批准号:
    9010414
  • 负责人:
  • 金额:
    $ 72.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-28 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Obesity is a significant national health problem that spares no age group. Approximately 10 percent of children less than two years of age in the U.S. have weight-for-length above the 95th percentile. Childhood obesity is particularly concerning for African American children. By ages 2 to 5 years, 19 percent of African American children are obese (BMI>95th percentile). Rapid weight gain in the first 4 to 6 months of life is associated with obesity later in childhood, so infancy may be a critical window for obesity prevention. This age range has other advantages for future prevention measures because of frequent contact with health care providers, parental control over infant diet, and the possibility that metabolic programming may occur in this developmental window. However, to develop public health strategies to prevent rapid weight gain in infancy, the causal factors must be well understood. Maternal BMI, gestational weight gain, birth delivery mode, antibiotic exposure, pattern of infant weight gain, feeding practices, maternal stress, socioeconomic status, population ancestry and genetic predisposition have been associated with childhood obesity risk, but their mechanisms of action, synergy, and relative importance remain unclear. Recent studies in animal models demonstrate cause-and-effect relationships between gut bacteria, their metabolites, and obesity development. In children and adults, alteration of gut microbiota is associated with obesity, and indirect effects of microbiota on appetite regulation have been implicated. Changes in gut microbiota in the first 2 years of life have been documented. A major knowledge gap is the link between changes in gut microbiota and its metabolome and excess weight gain during this young age. This is a prospective longitudinal study of children ages birth to 24 months. We will enroll pregnant African American women and their healthy, term infants, to achieve a sample of 300 evaluable infants at 24 months of age. We will collect epidemiological (maternal BMI, gestational weight gain, delivery mode, growth trajectory, antibiotic exposure), behavioral (sucking behavior, feeding practices, diet) and hormonal (appetite and metabolism regulating) parameters known to be associated with childhood obesity, as well as stool and plasma to analyze gut microbiota and the plasma metabolome. We will use mediation analysis to integrate known epidemiologic risk factors, intestinal microbiota, and metabolomic and hormonal biomarkers to identify potential mechanisms and modifiable factors underlying early excess weight gain. We hypothesize that early introduction of foods and non-recommended types of complementary foods will be associated with alterations in gut microbiota, the metabolome and hormonal milieu, resulting in early rapid weight gain in infancy and excess weight gain by age 2years. These findings will provide new insights into factors influencing childhood obesity, will serve to generate hypotheses for more mechanistic studies, and will likely have significant clinical utility in developing effective obesity prevention strateies in this critical developmental stage.
 描述(由申请人提供):肥胖是一个重要的国家健康问题,没有年龄组。在美国,大约10%的两岁以下儿童的身高体重超过第95百分位数。儿童肥胖症对非裔美国儿童来说尤其令人担忧。到2至5岁时,19%的非裔美国儿童患有肥胖症(BMI>第95百分位数)。在出生后的前4到6个月内体重快速增加与儿童期的肥胖有关,因此婴儿期可能是预防肥胖的关键窗口。这一年龄范围对于未来的预防措施还有其他优势,因为与卫生保健提供者的频繁接触,父母对婴儿饮食的控制,以及 代谢程序可能发生在这个发育窗口期。然而,要制定公共卫生战略,以防止婴儿期体重迅速增加,必须充分了解因果因素。母亲BMI、妊娠期体重增加、分娩方式、抗生素暴露、婴儿体重增加模式、喂养习惯、母亲压力、社会经济地位、人口血统和遗传倾向与儿童肥胖风险相关,但其作用机制、协同作用和相对重要性仍不清楚。最近在动物模型中的研究表明,肠道细菌及其代谢产物与肥胖发展之间存在因果关系。在儿童和成人中,肠道微生物群的改变与肥胖有关,微生物群对食欲调节的间接影响也有牵连。已经记录了生命最初2年内肠道微生物群的变化。一个主要的知识差距是肠道微生物群及其代谢组的变化与这个年轻时期体重过度增加之间的联系。这是一项对出生至24个月的儿童进行的前瞻性纵向研究。我们将招募非裔美国孕妇及其健康足月婴儿,以获得300例24月龄可评价婴儿的样本。我们将收集已知与儿童肥胖相关的流行病学(母体BMI、妊娠期体重增加、分娩方式、生长轨迹、抗生素暴露)、行为(吸吮行为、喂养习惯、饮食)和激素(食欲和代谢调节)参数,以及粪便和血浆,以分析肠道微生物群和血浆代谢组。我们将使用中介分析来整合已知的流行病学风险因素,肠道微生物群,代谢组学和激素生物标志物,以确定潜在的机制和可改变的因素,这些因素是早期体重过度增加的基础。我们假设,早期引入食物和非推荐类型的辅食将与肠道微生物群、代谢组和激素环境的改变相关,导致婴儿期早期体重快速增加,到20岁时体重过度增加。这些发现将为影响儿童肥胖的因素提供新的见解,将有助于产生更多机制研究的假设,并可能在这一关键发育阶段制定有效的肥胖预防策略方面具有重要的临床实用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY D. WU其他文献

GARY D. WU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY D. WU', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    9983081
  • 财政年份:
    2020
  • 资助金额:
    $ 72.72万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10200776
  • 财政年份:
    2020
  • 资助金额:
    $ 72.72万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9762892
  • 财政年份:
    2019
  • 资助金额:
    $ 72.72万
  • 项目类别:
Host-Microbial Analytic and Repository Core
宿主微生物分析和储存库核心
  • 批准号:
    9762893
  • 财政年份:
    2019
  • 资助金额:
    $ 72.72万
  • 项目类别:
Infant Growth and Microbiome Study 2
婴儿生长和微生物组研究 2
  • 批准号:
    9150589
  • 财政年份:
    2015
  • 资助金额:
    $ 72.72万
  • 项目类别:
Infant Growth and Microbiome Study 2
婴儿生长和微生物组研究 2
  • 批准号:
    9769010
  • 财政年份:
    2015
  • 资助金额:
    $ 72.72万
  • 项目类别:
Host-microbial interactions in the gut oxygen equilibrium
肠道氧平衡中宿主-微生物的相互作用
  • 批准号:
    8995209
  • 财政年份:
    2012
  • 资助金额:
    $ 72.72万
  • 项目类别:
Host-microbial interactions in the gut oxygen equilibrium
肠道氧平衡中宿主-微生物的相互作用
  • 批准号:
    8412823
  • 财政年份:
    2012
  • 资助金额:
    $ 72.72万
  • 项目类别:
Host-microbial interactions in the gut oxygen equilibrium
肠道氧平衡中宿主-微生物的相互作用
  • 批准号:
    8595322
  • 财政年份:
    2012
  • 资助金额:
    $ 72.72万
  • 项目类别:
Host-microbial interactions in the gut oxygen equilibrium
肠道氧平衡中宿主-微生物的相互作用
  • 批准号:
    8779726
  • 财政年份:
    2012
  • 资助金额:
    $ 72.72万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.72万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了